Disturbed equilibrium of the metalloproteinase/tissue inhibitors system, destabilization of atherosclerotic plaque, and acute coronary syndrome (ACS) in patients are caused by increased expression of MMP-2 and MMP-9 metalloproteinases and their tissue inhibitor (TIMP-2) [140]. This evidence concerns the gene MMP2 and acute coronary syndrome.